Načítá se...
Nano-Antagonist Alleviates Inflammation and Allows for MRI of Atherosclerosis
Specific targeting of inflammation remains a challenge in many pathologies, because of the necessary balance between host tolerance and efficacious inflammation resolution. Here, we discovered a short, 4-mer peptide which possesses antagonist properties towards CC chemokine receptor 2 (CCR2), but on...
Uloženo v:
| Vydáno v: | Nanotheranostics |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ivyspring International Publisher
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6838142/ https://ncbi.nlm.nih.gov/pubmed/31723548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ntno.37391 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|